Merck (MRK) Falls 10% in 3 Months: Should You Buy the Dip?

Merck’s (MRK) stock has declined 10% in the past three months against an increase of 9% for the industry. The stock has also underperformed the sector and S&P 500 index, as seen in the chart below.Merck Stock Underperforms Industry, Sector & S&P 500Image Source: Zacks Investment ResearchMerck’s stock started declining after the company announced second-quarter results on Jul 25. Though the company beat earnings and sales estimates and also slightly raised the full-year guidance for revenues, the stock took ...